update: ASGN 6.3
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
SECOND QUARTER HIGHLIGHTS
* Revenues for the quarter totaled $57,408,000, up 24.0% year over year
and above the Company's previously announced estimates. Lab Support
segment revenues were up 18.2%, Medical Financial & Allied (MF&A)
revenues were up 43.5% and Nurse Travel revenues were up 23.4% versus
the second quarter of 2004.
* Gross margin for the quarter was 26.7%, an improvement of 70 basis
points (bps) year over year.
* Selling, General & Administrative expenses (SG&A) were down $418,000
to $15,556,000 from the previous quarter.
* Net income for the quarter was $146,000, including an income tax
benefit of $240,000, an improvement of $3,017,000 from the preceding
quarter's net loss.
* Cash, cash equivalents, restricted cash and marketable securities
totaled $25,673,000 at June 30, 2005, an increase of $2,862,000 from
the preceding quarter. |
